AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests


Well-known member
Dec 11, 2018
AbbVie is giving up its patents on a combination drug that is being studied as a coronavirus treatment, becoming the first major drugmaker to drop its rights to make money from a drug that might be used during the pandemic.

The US drugmaker will no longer enforce patents relating to Kaletra anywhere in the world for all formulations, according to the Medicines Patent Pool, a UN-backed non-governmental organisation.
Kaletra is a combination of two antivirals — lopinavir and ritonavir — and is usually used to treat HIV. But some doctors have turned to it for treating patients with coronavirus, and its efficacy is being studied in several clinical trials, including one by the World Health Organization.

Latest content

General chat
Help Show users
  • No one is chatting at the moment.
  • blaqdu @ blaqdu:
    eeh yoooo!!!
  • E @ elreydelaswasas1:
    which of the following videogames has more combat moves Tekken 7 Fated Retribution Round 2 for online mode in teknoparrot emulator,Dead or Alive 6 for online move in teknoparrot emulator, Dead or Alive 6 for online mode in pc, Solucalibur 6 for online mode in pc ?
  • E @ elreydelaswasas1:
    Solucalibur 6 = Soulcalibur 6
  • M @ matyyyy:
    Good morning !! How are you ?? I found something crazy to try!
    M @ matyyyy: Good morning !! How are you ?? I found something crazy to try!